Current status and future trends of pharmaceutical glass bottle market
The pharmaceutical glass bottle market has shown a trend of sustained growth in recent years, mainly due to the rapid development of the pharmaceutical industry and the high requirements for drug safety. Medium-borosilicate pharmaceutical glass is considered to be an ideal choice for drug packaging due to its excellent properties, such as chemical resistance, resistance to temperature changes, water resistance and biocompatibility. Although the penetration rate of medium-borosilicate pharmaceutical glass in the Chinese market is less than 10%, its market demand is gradually increasing with the rapid development of the domestic pharmaceutical industry and the increasing requirements for drug safety.
Market size and growth trend
According to statistics, the size of China's pharmaceutical glass market continues to grow. In 2023, the scale of China's pharmaceutical glass market is about 35 billion yuan, and it is expected to reach 44.2 billion yuan by 2026, with a compound annual growth rate of 8.51%. Globally, the sales of pharmaceutical medium-borosilicate glass bottles in 2023 is 597 million US dollars, and it is expected to reach 924 million US dollars in 2030, with a compound annual growth rate of 6.5%.
Market competition pattern and major companies
In the Chinese market, Shandong Pharmaceutical Glass Co., Ltd. (Shandong Yaobo) is one of the largest pharmaceutical glass packaging companies. The company focuses on providing various specifications of glass packaging products to pharmaceutical manufacturers. Although its financial performance is good, market sentiment and capital inflows still need attention. In addition, low-borosilicate glass and high-borosilicate glass also occupy a certain share in the market, but medium-borosilicate glass is internationally recognized as a safe packaging material due to its excellent performance.